Abstract. The yeast nuclear envelope protein NSP1 is located at the nuclear pores and mediates its essential function via the carboxy-terminal domain. The passenger protein, cytosolic dihydrofolate reductase from mouse, was fused to the 220 residue long NSP1 carboxy-terminal domain. When expressed in yeast, this chimeric protein was tightly associated with nuclear structures and was localized at the nuclear periphery very similar to authentic NSP1. Furthermore, the DHFR-C-NSP1 fusion protein was able to complement a yeast mutant lacking a functional NSP1 gene showing that DHFR-C-NSP1 fulfils the same basic function as compared to the endogenous NSP1 protein. These data also show that the NSP1 protein is composed of separate functional moieties: a carboxyterminal domain that is sufficient to mediate the association with the nuclear periphery and an aminoterminal and middle repetitive domain with an as yet unknown function. It is suggested that heptad repeats found in the NSP1 carboxy-terminal domain, which are similar to those found in intermediate filament proteins, are crucial for mediating the association with the nuclear pores.
T HE nuclear pores are the sites of transport of proteins and nucleic acids between the nuclear and cytoplasmic compartments (for review, Dingwall and Laskey, 1986; Gerace and Burke, 1988) . The transport through the pores is mediated by specific nuclear targeting signals that are found in many nuclear proteins and recognized by receptors presumably located at the nuclear periphery and the nuclear pores (Kalderon et al., 1984; Newmeyer and Forbes, 1988;  for review see also, Gerace and Burke, 1988) . Nuclear pores are composed of supramolecular complexes, the nuclear pore complexes, which reveal an octagonal symmetry in the electron microscope and have an estimated molecular mass of approximately 100 x 10 ~ D (Unwin and Milligan, 1982; Reichelt et al., 1990) . Several components of the nuclear pores have been identified and a role in nuclear transport has been proposed for a few of them (Gerace et al., 1982; Blobel, 1986, 1987; Park et al., 1987; Snow et al., 1987) . Recently, cDNA probes for nuclear pore proteins were cloned and the DNA sequence and the deduced amino acid sequence of nuclear pore proteins is now available (D'Onofrio et al., 1988; Wozniak et al., 1989; Starr et al., 1990) . Nuclear pore proteins have been identified in yeast (Ads and Blobel, 1989; Nehrbass et al., 1990; Davis and Fink, 1990) and an essential role in nuclear envelope functions has been implied (Nehrbass et al., 1990) . By immunological cross-reactivity, it has been shown that the yeast nuclear pore proteins NSP1 and NUP1 are evolutionarily related to the mammalian nucleoporins of which p62 is the most prominent member (Davis and Blobel, 1986) .
So far, nothing is known aboUt how nuclear pore proteins reach their final destination. This information, however, is crucial to understand the assembly of nuclear pore complexes and to piece together the mechanism by which nuclear proteins are targeted to the nuclear pores and imported into the nucleus. To address this problem, we analyzed the different domains of NSP1, a yeast nuclear pore protein, for their role in nuclear targeting and nuclear pore association.
Here, we demonstrate that the 220 amino acid long carboxy-terminal domain of NSP1 contains signals to guide a murine cytosolic protein, dihydrofolate reductase, to the nuclear periphery, most likely to the nuclear pores. This is the first demonstration of a sequence mediating nuclear envelope association.
Materials and Methods

Yeast Strains and Media
The diploid yeast strain JU4.2 x JR26-19B (a/c~, ade2-1/ade2-1, ade8/ADE8, cardA00/canl-100, his4/HIS4, his3/HIS3, leu2-3/leu2-3, lysl-1/lysl-1, ura3-52/ura3-52) and TF2 heterozygous for NSPI (a/c~, ade2-1/ade2-1, adeS/ADE8, canl-100/card-100, his4/HIS4, his3/HIS3, leu2-3/!eu2-3, lysl-1/lysl-1, ura3/nspl::URA3/NSP1) have been used (Hurt, 1988) . Strains were grown in rich YPD (yeast extract, peptone, D-glucose) medium or minimal medium containing glucose or galactose as described in Hurt, 1988 . Figure 1 . Construction of a fusion protein consisting of the cytosolic protein dihydrofolate reductase and the NSP1 carboxyterminal domain. Schematic representation of the authentic NSP1 protein, the NSP1 carboxy-terminal domain alone , the fusion protein between eytosolic dihydrofolate reduetase from mouse and the NSP1 carboxy-terminal domain (DHFR-C-NSPI) and authentic dihydrofolate reductase (DHFR) . Details for construction of the chimeric gene DHFR-C-NSP1, and its expression in yeast are outlined under Materials and Methods. Amino acid numbers are indicated below the schematic drawings.
Construction of a Haploid
consisting of the entire dthydrofolate reductase coding sequence (residues 1-187), linker amino acids (G-W-K-I-R-G-S) and the carboxy-terminai NSPl-domain (from residues 606-823; see also Nehrbass et al., 1990) was placed under the control of the alcohol dehydrogenase (ADH) t I promoter (Hurt et al., 1985) . The hybrid gone was inserted into a 2t~ plasmid CYEP13; Sherman et aL, 1986) carrying the LEU2 gene as a selectable marker. The derived recombinant plasmid is named YEPI3-ADHI-DHFR-C-NSP1. The 1. Abbrevian'on used in this paper: ADH, alcohol dehydrogenase. diploid strain TF2 heterozygous for NSP1 was transformed with this plasmid and LEU+-transformants were selected (Itoh et al., 1983) .
Transformants were sporulated and tetrads dissected. All four spores of such tetrads were viable and no significant growth difference between tetrad spores was evident. URA+/LEU + haploid progeny contained a disrupted NSP1 gene and expressed only the fusion protein of mouse dihydrofolate reductase linked to the COOH-terminal domain of NSP1 under the constitutively active ADH I promoter as shown by immunoblotting.
To express authentic DHFR in yeast, the gene for mouse DHFR was inserted into plasmid pLGSD5 (Guarente et ai., 1982) under the control of the GALl0 promoter (Hurt et at., 1985) and transformed into the strain JU4.2 x JR26-19B. Expression of DHFR was induced by growing the cells in medium containing gaiactose (Guarente et at., 1982) .
Immune Sera, Affinity Purification of Antibodies, Indirect Immunofluorescence, and Immunoelectron Microscopy
Immune sera raised against Escherichia coil expressed NSPI (serum EC7-3 and EC9-3; see also Hurt, 1988) and mouse dihydrofolate reductase (UM15-3; kindly provided by Dr. G. Schatz, Basel, Switzerland) were used. Immune serum EC7-3 contained mainly antibodies against NSP1; immune serum EC9-3 also contained antibodies cross-reactive with NSP2. Antibodies against NSPl were affinity purified as described earlier (Nehrbass et al., 1990) . Antibodies against DHFR were affinity purified using purified mouse DHFR (Sigma Chemical GmbH, Munich, Federal Republic of Germany), which was immobilized by blotting onto nitrocellulose. For indirect immunofluorescence, affinity-purified antibodies from five consecutive elations were concentrated to ",,50 ~tl by ultrafiltration.
Indirect immunoltuorescence on yeast cells (Nehrbass et al., 1990 ) and isolated nuclei was performed as described earlier; in particular, yeast cells were fixed in 3 % formaldehyde before spheroplasting and nuclei were als0 fixed in 3 % formaldehyde before the latter were centrifuged on polylysine-coated coverslips. For indirect immunofluorescence, affinity-purified anti-NSFl and anti-DHFR antibodies in a 1:5 dilution were used followed by a second antibody, Texas red-labeled goat anti-rabbit IgG, in a 1:100 dilution. For DNA staining, 0.5/~g/ml Hoechst 33258 was used. Labeled cells were inspected in a Zeiss Axiophot fluorescence microscope using the Plan-Neofluar 100x/1.3 objective and pictures were taken with tein corrg~osed of mouse DHFR and the carboxy-terminal domain of NSP1 was carried out as described in Materials and Methods. Yeast cells were grown in minimal glucose medium supplemented with the appropriate nutrients and total protein extract was prepared. Aliquots of the yeast and E. coli extracts were separated on a SDS-12% polyacrylamide gel followed by immunoblotting using affinitypurified antibodies against mouse DHFR (leO) and the immune serum EC9-3 made against NSP1 (right). Lane 1, purified mouse DHFR (1 ~g; Sigma Chemical GmbH); lane 2, yeast control strain (TF2); lane 3, yeast strain expressing the DHFR-C-NSP1 fusion protein (TF2 transformed with plasmid YEP13-ADHI-DHFR-C-NSP1); lane 4, extract from E. coli expressing the DHFR-C-NSP1 fusion protein under a bacteriophage promoter. The positions of mouse DHFR, the DHFR-C-NSP1 fusion protein, NSP1, and NSP2 are indicated by arrows. The molecular masses of a protein standard are also shown. Note that the immune serum EC9-3 made against NSP1 cross-reacts with an immunologically related protein NSP2 (Nehrbass et ai., 1990) , which is very prominent in the extract of TF2 transformed with plasmid YEP13-ADHI-DHFR-C-NSPI. We observed that the amount of immunodetectable NSP2 can vary in a strain-dependent way. [-ura-leu] 
plate)
indicating that they carried the disrupted nspl gene (disrupted by the URA3 gene) and plasmid YEPI3-ADHI-DI-IFR-C-NSPl (containing the LEU2 gene). Tetrad C only gave two viable spores which were ura-. Most likely this tetrad had lost the complementing plasmid YEPI 3-ADHI-DHFR-C-NSP1 during growth on the sporulation plate (YPA plate). (B) Immunoblot analysis. Protein extracts derived from a complete tetrad from strain TF2 heterozygous for NSPI and transformed with plasmid YEP13-ADHI-DHFR-C-NSP1 were analyzed by SDS-12% polyacrylamide gel electrophoresis and immunoblotting using anti-NSPl antibodies. Immune serum EC7-3 was used, which reacts only with NSPI and the DHFR-C-NSP1 fusion protein, but not with NSP2. Lane 1, diploid yeast strain expressing the DHFR-C-NSP1 fusion protein (TF2 transformed with plasmid YEP13-ADHI-DHFR-C-NSPI); lanes 2-5, haploid progeny from a tetrad derived from TF2 transformed with plasmid YEPI3-ADHI-DHFR-C-NSP1; lanes 2 and 3, haploid progeny expressing only the DHFR-C-NSP1 fusion protein (URA+/LEU+); lanes 4 and 5, haploid progeny expressing only authentic NSP1 (ura-/leu-); plasmid YEP13-ADHI-DHFR-C-NSP1 was segregated out from these two haploid progeny; lane 6, protein extract from E. coli expressing the DHFR-C-NSP1 fusion protein under a bacteriophage promoter. The position of the DHFR-C-NSP1 fusion protein and NSPI is indicated by arrows. The molecular masses of a protein standard are also given.
TMY 400 film. Immunoelectron microscopy using aliinity-puritied anti-DHFR antibodies was subsequently performed (Griffiths et al., 1984; Nehrbass et al., 1990) .
Extraction of Proteins from Yeast Cells, SubceUular and Subnuclear Fractionation and lmmunoblotting
Total protein extracts from yeast were prepared by resuspending freshly harvested cells from a 50~ml culture (OD 600 nm of 1) in 1.5 ml hot SDS sample buffer. The sample was vortexed together with 400 micron glass beads followed by a 20-rain incubation at 96°C with occasional vortexing. The centrifuged extract corresponding to 1 0 D (600 nm) was applied on a SDS-polyacrylamide gel and separated proteins were blotted onto nitrocellulose. Filters were blocked by 2 % nonfat milk powder in PBS and immune sera were used in a 1:500 dilution. The protein bands were detected using protein A coupled to horseradish peroxidase.
Spheroplasting of yeast cells and subcellular fractionation including purification of nuclei was done as described earlier Figure 4 . The DHFR-C-NSPI fusion protein is localized at the nuclear periphery and nuclear pores. Expression of the DHFR-C-NSP1 fusion protein in a haploid yeast nspl-strain and indirect immunofluorescence microscopy are described in Materials and Methods. (A) Indirect immunofluorescence microscopy using affinity-purified anti-DHFR antibodies on haploid yeasts with disrupted nspl and expressing the DHFR-C-NSPI fusion protein (top). Cells were also stained for DNA with Hoeehst 33258 (bottom). The immunofluorescence staining was punctate and patchy at the nuclear periphery, typical for nuclear pore labeling and highly similar to NSP1 immunolabeling (see also, Nehrbass et al., 1990) . (B) Indirect immunofluoreseence microscopy on yeast expressing authentic dihydrofolate reduetase from mouse.
Immunolabeling using anti-DHFR antibodies (top) and DNA-staining (bottom) is shown. (C) Indirect immunofluorescence microscopy on purified nuclei isolated from yeast expressing the DHFR-C-NSP1 fusion protein and authentic dihydrofolate reduetase (DHFR) from mouse. Immunolabeling using anti-DHFR antibodies and DNA staining is shown.
Differential extraction of purified yeast nuclei with DNAse/RNAse, Triton X-100, and 500 mM NaC1 was essentially as described (Aris and Blobei, 1989) . Aliquots of the different subcellular fractions (onefold cell aliquot of the homogenate and postnuclear supernatant; a 10-fold cell aliquot of the crude nuclear pellet and the sucrose gradient fractions), as well as equal equivalents of the subnuclear fractions, were analyzed by SDS-PAGE and immunoblotting as described above.
Results
In Vivo Expression of the Fusion Protein Between Dihydrofolate Reductase and the NSP1 Carboxy-Terminal Domain (DHFR-C-NSP1) in Yeast
The carboxy-terminal domain of NSP1 contains all the information to complement a yeast mutant lacking a functional nspl gene (Nehrbass et al., 1990) . Since antibodies against this domain did not stain the yeast cells by indirect immunofluorescence, we could not determine its exact location within the nuclear compartment. We therefore decided to tag this domain with a new epitope and attached to its amino terminus a reporter protein, cytosolic dihydrofolate reductase from mouse. We then analyzed whether the fusion protein can be targeted to the nuclear periphery. The behavioral properties of the dihydrofolate reductase protein make it an excellent marker for the study of intracellular organelle targeting (Hurt et al., 1984) . If expressed in yeast, DHFR exclusively partitions into the cytosolic fraction whereas if linked to a mitochondrial presequence, it is targeted to the mitochondrial matrix (Hurt et al., 1985) . The fusion protein consisting of the entire dihydrofolate reductase coding sequence (187 residues), a short spacer sequence (7 residues), and the NSP1 carboxy-terminal domain from residues 606-823 (Fig. 1) was expressed in yeast under the control of the alcohol dehydrogenase promoter. Expression was demonstrated by immunoblotting using affinity-purified antibodies against mouse DHFR or an immune serum made against yeast NSP1 (Fig. 2, lane 3, left and right) . A fusion protein of ~53 kD on SDS-polyacrylamide gels was seen on the immunoblot; the predicted molecular mass according to the amino acid sequence was calculated to be 47 kD. Thus, the fusion protein migrates slightly abnormal on SDS-poly- acrylamide gels. No band at the position of the fusion protein was seen in a control yeast strain (Fig. 2, lane 2) . The fusion protein reacted with both the anti-DHFR and anti-NSP1 antibodies. The immunoreaction with anti-DHFR antibodies was highly specific for the DHFR-C-NSP1 fusion protein giving only one protein band on the immunoblot with no apparent proteolytic breakdown (Fig. 2, lane 3, anti-DHFR) . Thus, the DHFR-C-NSP1 fusion protein is stably expressed in yeast. In contrast, the authentic NSP1 protein is susceptible to proteolysis even in living cells (see also, Fig. 3 B and Hurt, 1988) . The observed proteolytic sensitivity of authentic NSPI is mainly due to the presence of repetitive sequences within the central NSP1 domain. If the DHFR-C-NSP1 is expressed in E. coli, the fusion protein is proteolytically cleaved to a significant extent and a breakdown product corresponding roughly in size to the DHFR moiety becomes evident (Fig. 2, lane 4) .
The Fusion Protein Between Dihydrofolate Reductase and the NSP1 Carboxy-Terminal Domain Can Complement the Nonviable Yeast Mutant Lacking a Functional NSP1 Gene
We wanted to test whether the DHFR-C-NSP1 fusion protein, likewise the NSP1 carboxy-terminal domain alone, can complement a yeast mutant lacking a functional NSP1 gene. In the case of complementation we would argue that this domain folds and acts independently from the rest of the NSP1 protein. The gene coding for the fusion protein was therefore placed under the control of the constitutively active yeast alcohol dehydrogenase promoter, inserted into a 2# plasmid Figure 5 . The DHFR-C-NSP1 fusion protein cofractionates with nuclei. Expression of DHFR-C-NSPI and authentic DHFR in yeast and subcellular fractionation was performed as described in Materials and Methods. Subcellular fractionation of a haploid yeast strain devoid of authentic NSP1, but expressing the DHFR-C-NSPI fusion protein (YEP13-AHDI-DHFR-C-NSP1 ) and of a yeast strain expressing authentic
DHFR (pLGSDS-DHFR ).
Aliquots of total cell homogenate (H), postnuclear supernatant (PNS), crude nuclear pellet (NP), and fraction I to V of a final sucrose gradient were analyzed by SDS-12% polyacrylamide gel electrophoresis and immunoblotting using an immane serum against NSPI and NSP2 (EC9-3, top), against the nuclear marker NOPI (bottom inset in top) and against mouse DHFR (lower panel). Nuclei, nuclear markers and the DHFR-C-NSPI fusion protein were recovered mainly in the crude nuclear pellet (NP) and in fraction IV of the final sucrose gradient. The positions of the fusion protein, NSP2, and NOP1, and of authentic DHFR are indicated by arrows. The molecular masses of a protein standard are also shown. and transformed into the diploid yeast strain TF2 heterozygous for NSP1. Expression of the fusion protein could be shown by immunoblotting using antibodies against NSP1 and dihydrofolate reductase (Fig. 3 B , lane 1; see also Fig. 2, lane  3) . This diploid transformant was sporulated to obtain haploid progeny and after tetrad dissection, four viable tetrad spores could be generally recovered (Fig. 3 A) . Haploid progeny from complete tetrads that contained the disrupted nspl gene copy and the 2# plasmid with the chimeric gene coding for the DHFR-C-NSP1 fusion protein showed no evident growth difference as compared to spores with authentic NSP1 (Fig. 3 A) . Therefore, complementation by the DHFR-C-NSP1 fusion protein was not different from control strains with endogenous NSP1. Haploid progeny with disrupted nspl transformed with the chimeric gene expressed the fusion protein of •53 kD on SDS-polyacrylamide gels, but no NSP1 protein (Fig. 3 B, lanes 2 and 3) . Again the fusion protein was very stable in the complemented haploid cells and proteolytic breakdown products could not be seen. This clearly demonstrates that a fulllength DHFR-C-NSP1 fusion protein and not a proteolytic fragment corresponding to the NSP1 carboxy-terminal domain caused the in vivo complementation of the yeast mutant lacking a functional NSP1.
The DHFR-C-NSP1 Fusion Protein Is Located at the Nuclear Periphery
From the complementation studies performed above it was concluded that the carboxy-terminal domain of NSP1 can target a cytosolic protein to the nuclear periphery and nuclear pores. To directly demonstrate this result, we performed indirect immunofluorescence to determine the exact location of the DHFR-C-NSP1 fusion protein within the yeast cell using DHFR-specific antibodies (Fig. 4) . Affinitypurified anti-DHFR antibodies, which on immunoblots reacted only with the fusion protein, but not with NSP1 (see also Fig. 2 ), predominantly stained the nuclear periphery of yeast cells complemented by the NSP1 carboxy-terminal moiety of the chimeric protein (Fig. 4 A) . The staining of the nuclear boundary was often punctate or patchy, which was highly similar to the authentic NSP1 immunolabeling and thus typical for nuclear pore labeling in yeast (see also Aris and Blobel, 1989; Nehrbass et al., 1990; Davis and Fink, The Journal of Cell Biology, Volume i I 1, 1990 Figure 6 . The DHFR-C-NSP1 fusion protein is enriched in the insoluble nuclear fraction. Subfractionation of purified nuclei containing the DHFR-C-NSP1 fusion protein was performed essentially as described (Ads and Blobel, 1989) . Nuclei (50 ttg) were digested with DNAse/RNAse and centrifuged to yield a supernatant and pellet. Nuclear envelopes were further treated with 1% Triton X-100 or 500 mM NaC1 to obtain a supernatant and a pellet fraction. Identical equivalents of the pellet (P) and supernatant (S) fractions were separated on a SDS-12% polyacrylamide gel and immunoblotted using anti-NSP1/NSP2 (EC9-3; top) and NOP1 antibodies (bottom). The positions of the DHFR-C-NSP1 fusion protein, NSP2, NOP1, and the molecular mass of a protein standard are indicated by arrows and lines. 1990). In contrast, authentic DHFR expressed in yeast was found throughout the cell (Fig. 4 B) . This confirms the eytosolic location of DHFR which is also indicated by subcellular fractionation (see also Fig. 5 ). In addition, nuclei isolated from the yeast strain expressing the DHFR-C-NSP1 fusion protein showed a ring-and dot-like staining of the nuclear membrane in contrast to nuclei from a strain expressing authentic DHFR, which only gave background labeling (Fig.  4 C) . Thus, the punctate and ring-like labeling of the nuclear periphery visualized by indirect immunofluorescence is consistent with the in vivo complementation studies and directly demonstrates that the DHFR-C-NSPI fusion protein, like authentic NSP1, is localized at the nuclear periphery, most likely the nuclear pores. Whether all of the fusion protein is located at the nuclear pores or a portion of it can be also associated with other nuclear structures can not be decided since immuno-EM did not satisfactorily work. However, it is not our aim in this paper to give a quantitative estimate of the efficiency of nuclear pore association, which in the light of an artificial gene fusion approach would be difficult to interpret.
The DHFR-C-NSP1 Fusion Protein Cofractionates with Nuclei and the Insoluble Nuclear Fraction
We were interested to analyze by biochemical means the efficiency of nuclear targeting and the association of the DHFR-C-NSP1 fusion protein with nuclear envelopes in the complemented yeast strain. We recently reported a subcellular fractionation protocol for Saccharomyces cerevisiae that allows the efficient and reliable purification of yeast nuclei . Using this technique, we performed a subcellular (Fig. 5 ) and subnuclear fractionation (Fig. 6 ) of strains expressing authentic dihydrofolate reductase or the DHFR-C-NSP1 fusion protein. Whereas mouse DHFR was exclusively found in the postnuclear supernatant of yeast cells, but not in the crude nuclear pellet or purified nuclei (Fig. 5, bottom) , the fusion protein consisting of DHFR linked to the NSP1 carboxy-terminal domain cofractionated with nuclei and the nuclear markers NOP1 (Fig. 5, top) and histone H2B (data not shown).
After subnuclear fractionation, which allows a distinction between loosely bound and tightly associated nuclear proteins (Ads and Blobel, 1989) , the DHFR-C-NSP1 fusion protein was not significantly extracted from purified nuclei by DNAse, RNAse, or detergent, and was only partially released by high salt treatment, a condition that completely releases the nucleolar protein NOP1 (Fig. 6) . Applying the same subnuclear fractionation protocol, NSP1 is to a similar extent enriched in the salt-resistant nuclear fraction that is often referred as to the "pore complex/lamina" preparation (data not shown).
In summary, biochemical data, indirect immunofluorescence, and in vivo complementation studies demonstrate that the biochemical properties, as well as the subcellular and subnuclear location of the DHFR-C-NSP1 fusion protein, are comparable to those of authentic NSP1. We therefore conclude that the chimeric protein is associated with the nuclear periphery, can be found at the nuclear pores and fulfils the same essential function as the endogenous NSP1.
Discussion
In this work we have addressed the question of how a protein can associate with the nuclear periphery and nuclear pores. The targeting of macromolecules to the nuclear pores can occur by different mechanisms. Proteins destined for the nuclear interior and initially synthesized in the cytosol carry specific nuclear targeting signals that guide them first to the nuclear pores and further mediate translocation through the nuclear pore complexes (Dingwall and Laskey, 1986; Newmeyer and Forbes, 1988) . It was shown that nuclear proteins can bind to components located at the nuclear periphery and the nuclear pores (Newmeyer and Forbes, 1988; Akey and Goldfarb, 1989) and these nuclear envelope constituents may be receptors of the nuclear localization signals. In addition, cytosolic factors, which also specifically bind to nuclear proteins, have been identified and a role in nuclear transport has been suggested (Adam et al., 1989; Yamasaki et al., 1989; Newmeyer and Forbes, 1990) . However, the mechanism by which components of the nuclear pore complexes or putative receptors for nuclear proteins associated with the nuclear pores reach their correct subnuclear location, is still unknown. These questions have not been addressed so far, since only a few components of the nuclear pores had been identified and little is known about their structure and regulation. We recently identified in yeast an evolutionarily conserved and essential nuclear envelope protein, NSP1, which is located at the nuclear pores (Hurt, 1988; Nehrbass et al., 1990) . NSP1 reveals a three domain organization as deduced from the primary amino acid sequence and we therefore asked which of these domains can mediate the interaction with the nuclear pores. By using a gene fusion approach, we show here that the carboxy-terminal domain of NSPI is sufficient to direct a cytosolic protein, murine DHFR, to the nuclear membrane and nuclear pores. Sequences derived from the central repetitive NSP1 domain could not mediate a peripheral nuclear location of E. coli B-galactosidase, although the fusion protein was found inside the nucleus (Nehrbass et al., 1990) . However, this B-galactosidase fusion protein may be too bulky (because of tetramerization) to become stably assembled into peripheral nuclear structures. Therefore, we are currently testing whether a fusion protein consisting of repeat sequences from the NSP1 middle domain and dihydrofolate reductase is localized at the nuclear periphery and the nuclear pores (Nehrbass, U., unpublished data) .
NSP1 Heptad Repeats
What Is the Molecular Basis for the Association of the NSP1 Carboxy-Terminal Domain with the Nuclear Pores?
The entire sequence of the NSP1 earboxy-terminal domain is organized into heptad repeats, i.e., a periodic disposition of apolar residues at positions a and d within a heptad repeat of the form a b c d e f g (Fig. 7) . This type of heptad repeat is typically found in intermediate filament proteins such as lamins and cytokeratins which can form alpha-helical coiled-coils (Steinert and Poop, 1988) . Interestingly, the existence of yeast lamin A and B analogous has been recently suggested (Georgatos et al., 1989) . Secondary structure predictions based on the algorithmic program of Chou and Fasman (1978) suggest that several alpha-helical segments occur throughout the entire NSP1 carboxy-terminal domain that may be formed through interactions of the hydrophobic residues of heptad repeats either with each other or with another protein containing similar sequence repeats.
Consistent with this model is that a mutation in one of the NSP1 carboxy-terminal heptad repeats (glutamic acid 706 in proline; see also Fig. 7) , which could interfere with the alpha-helical organization, results in severe impairment of the NSP1 function and temperature-sensitive growth of the mutant (Nehrhass et al., 1990) . In this mutant, NSP1 was no longer strictly associated with the nuclear periphery, but was also found in numerous aggregates in the cytosol (Nehrbass et al., 1990) .
Together, these results and those using the gene fusion approach suggest that the NSP1 carboxy-terminal domain contains signals that can specifically bind to component(s) located at the nuclear boundary, presumably the nuclear pores. This docking process may depend on alpha-helical interactions between amphipathic heptad repeats. Whether NSP1 first dimerizes through its carboxy-terminal domain and then binds to a receptor-like component at the nuclear pores, or whether the monomeric NSP1 carboxy-terminal directly interacts with a component of similar heptad repeat organization and located at the nuclear pores requires further clarification.
It is interesting to note that the carboxy-terminal domain of rat liver p62 nucleoporin (D'Onofrio et al., 1988) , a protein located at the nuclear pores in higher eucaryotes (Davis and Blobel, 1986 ) and implied to be involved in nuclear transport (Featherstone et al., 1988; Finlay and Forbes, 1990) , shows a distinct homology to the yeast NSP1 carboxyterminal domain (Carmo-Fonseca, M., and E. Hurt, manuscript in preparation) as well as a similar heptad repeat organization (Start et al., 1990) . Thus, this type of sequence motif may also mediate nuclear pore association in higher eucaryotes, and is conserved during evolution from yeast to man.
It is surprising that the carboxy-terminal domain is still functional, even when the globular and compactly folded di-hydrofolate reductase protein is attached to it. This strongly argues that authentic NSP1 is split up into different functional domains that fold and function independently from each other. We have identified at least one function of the carboxy-terminal domain that is involved in nuclear pore association. We will exploit the DHFR characteristics to identify putative docking components of NSP1 located at the nuclear pores by affinity ligand purification using methotrexate affinity columns. The function of the second domain, the highly repetitive central part of NSP1, is not known and functional analysis is more difficult to perform because it is not essential for cell growth. Interestingly, NSP1 repetitive sequences are also found in other nuclear proteins such as NUP1 (Davis and Fink, 1990 ) and NSP2 (Nehrbass et al., 1990) . NUP1 was shown to be localized to the nuclear pores. Thus, proteins with this new type of NSPl-like repetitive sequences seem to occur preferentially at the nuclear pores implying a pore-specific function. It remains to be shown whether NSP1 and NSPl-like proteins form a complex that associates with the nuclear pores.
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